Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?

Histopathology

Volumn 61, Issue 6, 2012, Pages 1214-1218

  Mationg Kalaw, Emarene ^a   Tan, Leonard H C ^b   Tay, Kevin ^c   Lim, Soon Thye ^c   Tang, Tiffany ^c   Lee, Yvonne Y L ^c   Tan, Soo Yong ^b  

^a NCCS VARI Translational Research Laboratory   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Chromosomal translocation; Diffuse; Ki 67 antigen; Large B cell; Lymphoma

Indexed keywords

CCND1 PROTEIN; IGH PROTEIN; KI 67 ANTIGEN; MALT1 PROTEIN; MEMBRANE PROTEIN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CELL PROLIFERATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BURKITT LYMPHOMA; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; FEMALE; GENETIC TESTING; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; KI-67 ANTIGEN; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; PROTO-ONCOGENE PROTEINS C-MYC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRANSLOCATION, GENETIC;

EID: 84870390243     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04351.x     Document Type: Article

References (10)

1. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84; 1361-1392.
2. Bertrand P, Bastard C, Maingonnat C et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 2007; 21; 515-523.
3. Haralambieva E, Boerma E-J, van Imhoff GW et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am. J. Surg. Pathol. 2005; 29; 1086-1094.
4. Hummel M, Bentink S, Berger H et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 2006; 354; 2419-2430.
5. Liu D, Shimonov J, Primanneni S, Lai Y, Ahmed T, Seiter K. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia. Mol. Cancer 2007; 6; 35.
6. Ueda C, Nishikori M, Kitawaki T, Uchiyama T, Ohno H. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. Int. J. Hematol. 2004; 79; 52-54.
7. Stein HWR, Chan WC, Jaffe ES, Chan JKC, Gatter KC, Campo E. Diffuse large B-cell lymphoma, not otherwise specified. In Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC, 2008; 233-237.
8. Salaverria I, Zettl A, Beã S et al. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica 2008; 93; 1327-1334.
9. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103; 275-282.
10. Mengel M, von Wasielewski R, Wiese B, Rudiger T, Muller-Hermelink HK, Kreipe H. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J. Pathol. 2002; 198; 292-299.